Else Announces Closing of Subsequent Institutional Investment For Gross Proceeds of US$2.5m
11 7월 2023 - 7:01AM
ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL)
(the “
Company”) is pleased to announce that it has
elected to exercise its right to increase the face value of its
convertible security by US$3 million under its previously announced
convertible security funding agreement (the
“
Agreement”) with Lind Global Fund II LP, an
entity managed by The Lind Partners, LLC, a New York-based
institutional fund manager (together, “
Lind”), for
additional net proceeds of US$2,420,012 after deduction of the
original issue discount and closing fees. As a result
of the exercise of the increase right, the total face value of the
convertible security was increased from US$5.1 million to US$8.1
million.
In connection with the increase, the Company
issued 3,591,776 common share purchase warrants exercisable into
common shares in the capital of the Company for a period of 48
months from the date of issuance at an exercise price of C$0.9058
per common share.
See the Company’s news release dated December
22, 2022 for additional information on the convertible
security.
This press release shall not constitute an offer
to sell or a solicitation of an offer to buy nor shall there be any
sale of the securities offered in any jurisdiction in which such
offer, solicitation, or sale would be unlawful. The securities
offered have not been registered under the United States Securities
Act of 1933, as amended (the “U.S. Securities Act”), or applicable
state securities laws, and may not be offered or sold to, or for
the account or benefit of, persons in the United States or U.S.
persons (as both such terms are defined in Regulation S promulgated
under the U.S. Securities Act) absent registration or an applicable
exemption from such registration requirements.
About Else Nutrition Holdings
Inc.
Else Nutrition Holdings Inc. (TSXV: BABY, OTCQX:
BABYF, FSE: 0YL) is a food and nutrition company in the
international expansion stage focused on developing innovative,
clean, and plant-based food and nutrition products for infants,
toddlers, children, and adults. Its revolutionary, plant-based,
non-soy formula is a clean-ingredient alternative to dairy-based
formulas. Since launching its Plant-Based Complete Nutrition for
Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the
brand has received thousands of powerful testimonials and reviews
from parents, gained national retailer support, and achieved rapid
sales growth.
Awards and Recognition:
-
"2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit
-
#1 Best Seller on Amazon in the Fall of 2020 in the New Baby &
Toddler Formula Category
-
“Best Dairy Alternative” Award 2021 at World Plant-Based Expo
-
Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category
-
During September 2022, Else Super Cereal reached the #1 Best Seller
in Baby Cereal across all brands on Amazon
For more information, visit
www.elsenutrition.com or @elsenutrition on Facebook and
Instagram.
About The Lind Partners
The Lind Partners manages institutional funds
that are leaders in providing growth capital to small- and mid-cap
companies publicly traded in the US, Canada, Australia and the UK.
Lind’s funds make direct investments ranging from US$1 to US$30
million, invest in syndicated equity offerings and selectively buy
on market. Having completed more than 150 direct investments
totaling over US$1.5 Billion in transaction value, Lind’s funds
have been flexible and supportive capital partners to investee
companies since 2011. For more information, please visit
http://www.thelindpartners.com.
For more information,
contact:Mrs. Hamutal Yitzhak, CEO, Co-Founder &
DirectorELSE Nutrition Holdings Inc.E: hamutaly@elsenutrition.com
P: +972(0)3-6445095
Mr. Sokhie Puar, Lead Director of Else
NutritionE: sokhiep@elsenutrition.com P : 604-603-7787
Investor Relations Contact:
RBMG – RB Milestone Group LLCTrevor Brucato, Managing DirectorE:
Baby@rbmilestone.com www.rbmilestone.com
Lytham Partners, LLCMr. Ben Shamsian New York |
Phoenix E: shamsian@lythampartners.com P:
646-829-9701TSX
Neither the TSX nor its regulation services provider (as that
term is defined in the policies of the TSX) accept responsibility
for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute "forward-looking statements" within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as "will" or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the company's financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs, and assumptions,
which are based on management's perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID-19 and that the
manufacturing, broker, and supply logistic agreement with the
company does not terminate. Actual results may differ from the
estimates, beliefs, and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management's expectations only as of the date of this press
release. The company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law.
Else Nutrition (TSX:BABY)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Else Nutrition (TSX:BABY)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024